Literature DB >> 1572982

Enzyme immunosorbent assay for Ebola virus antigens in tissues of infected primates.

T G Ksiazek1, P E Rollin, P B Jahrling, E Johnson, D W Dalgard, C J Peters.   

Abstract

A sandwich enzyme immunosorbent assay (EIA) using a mixture of mouse monoclonal antibodies for antigen capture and polyclonal hyperimmune rabbit anti-Ebola virus serum for antigen detection was developed and evaluated on the tissues of monkeys naturally or experimentally infected with strains of Ebola viruses. When compared with virus isolation, the antigen detection EIA was both sensitive and specific: 44 of 45 (97.7%) liver homogenates and 38 of 41 (92.7%) spleen homogenates that were culture positive and tested by both techniques were positive for viral antigen, while 85 of 87 (97.7%) culture-negative liver homogenates and 66 of 66 culture-negative spleen homogenates were found to be antigen negative. The assay, initially developed to detect antigens of prototype African strains of Ebola virus, reliably detected related strains of Ebola virus found during two recent outbreaks of Ebola virus infection among imported, quarantined Macaca fascicularis monkeys in the United States. The assay allows economical and rapid testing of large numbers of tissue specimens. Antigen was found in homogenates of spleen and liver and in serum.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1572982      PMCID: PMC265191          DOI: 10.1128/jcm.30.4.947-950.1992

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  11 in total

1.  Rapid diagnosis of Rift Valley fever: a comparison of methods for the direct detection of viral antigen in human sera.

Authors:  J Meegan; B Le Guenno; T Ksiazek; A Jouan; F Knauert; J P Digoutte; C J Peters
Journal:  Res Virol       Date:  1989 Jan-Feb

2.  A comparative study of strains of Ebola virus isolated from southern Sudan and northern Zaire in 1976.

Authors:  E T Bowen; G S Platt; G Lloyd; R T Raymond; D I Simpson
Journal:  J Med Virol       Date:  1980       Impact factor: 2.327

3.  Isolation and partial characterisation of a new virus causing acute haemorrhagic fever in Zaire.

Authors:  K M Johnson; J V Lange; P A Webb; F A Murphy
Journal:  Lancet       Date:  1977-03-12       Impact factor: 79.321

4.  Viral haemorrhagic fever in southern Sudan and northern Zaire. Preliminary studies on the aetiological agent.

Authors:  E T Bowen; G Lloyd; W J Harris; G S Platt; A Baskerville; E E Vella
Journal:  Lancet       Date:  1977-03-12       Impact factor: 79.321

5.  Antigenic analysis of strains of Ebola virus: identification of two Ebola virus serotypes.

Authors:  D D Richman; P H Cleveland; J B McCormick; K M Johnson
Journal:  J Infect Dis       Date:  1983-02       Impact factor: 5.226

6.  Biologic differences between strains of Ebola virus from Zaire and Sudan.

Authors:  J B McCormick; S P Bauer; L H Elliott; P A Webb; K M Johnson
Journal:  J Infect Dis       Date:  1983-02       Impact factor: 5.226

7.  Plaque assay for Ebola virus.

Authors:  J B Moe; R D Lambert; H W Lupton
Journal:  J Clin Microbiol       Date:  1981-04       Impact factor: 5.948

8.  Ebola virus: a comparison, at ultrastructural level, of the behaviour of the Sudan and Zaire strains in monkeys.

Authors:  D S Ellis; E T Bowen; D I Simpson; S Stamford
Journal:  Br J Exp Pathol       Date:  1978-12

9.  Pathophysiology of shock and hemorrhage in a fulminating viral infection (Ebola).

Authors:  S P Fisher-Hoch; G S Platt; G H Neild; T Southee; A Baskerville; R T Raymond; G Lloyd; D I Simpson
Journal:  J Infect Dis       Date:  1985-11       Impact factor: 5.226

10.  Preliminary report: isolation of Ebola virus from monkeys imported to USA.

Authors:  P B Jahrling; T W Geisbert; D W Dalgard; E D Johnson; T G Ksiazek; W C Hall; C J Peters
Journal:  Lancet       Date:  1990-03-03       Impact factor: 79.321

View more
  36 in total

1.  Recombinant monoclonal human antibodies against Ebola virus.

Authors:  N V Tikunova; A A Kolokol'tsov; A A Chepurnov
Journal:  Dokl Biochem Biophys       Date:  2001 May-Jun       Impact factor: 0.788

2.  Comparison of dissociation-enhanced lanthanide fluorescent immunoassays to enzyme-linked immunosorbent assays for detection of staphylococcal enterotoxin B, Yersinia pestis-specific F1 antigen, and Venezuelan equine encephalitis virus.

Authors:  D R Smith; C A Rossi; T M Kijek; E A Henchal; G V Ludwig
Journal:  Clin Diagn Lab Immunol       Date:  2001-11

3.  Antigen capture enzyme-linked immunosorbent assay for specific detection of Reston Ebola virus nucleoprotein.

Authors:  Tetsuro Ikegami; Masahiro Niikura; Masayuki Saijo; Mary E Miranda; Alan B Calaor; Marvin Hernandez; Luz P Acosta; Daria L Manalo; Ichiro Kurane; Yasuhiro Yoshikawa; Shigeru Morikawa
Journal:  Clin Diagn Lab Immunol       Date:  2003-07

Review 4.  Laboratory diagnostic systems for Ebola and Marburg hemorrhagic fevers developed with recombinant proteins.

Authors:  Masayuki Saijo; Masahiro Niikura; Tetsuro Ikegami; Ichiro Kurane; Takeshi Kurata; Shigeru Morikawa
Journal:  Clin Vaccine Immunol       Date:  2006-04

5.  What Ebola tells us about outbreak diagnostic readiness.

Authors:  Mark D Perkins; Mark Kessel
Journal:  Nat Biotechnol       Date:  2015-05       Impact factor: 54.908

6.  Emergence of divergent Zaire ebola virus strains in Democratic Republic of the Congo in 2007 and 2008.

Authors:  Gilda Grard; Roman Biek; Jean-Jacques Muyembe Tamfum; Joseph Fair; Nathan Wolfe; Pierre Formenty; Janusz Paweska; Eric Leroy
Journal:  J Infect Dis       Date:  2011-11       Impact factor: 5.226

7.  Digital sensing and sizing of vesicular stomatitis virus pseudotypes in complex media: a model for Ebola and Marburg detection.

Authors:  George G Daaboul; Carlos A Lopez; Jyothsna Chinnala; Bennett B Goldberg; John H Connor; M Selim Ünlü
Journal:  ACS Nano       Date:  2014-06-04       Impact factor: 15.881

8.  Monoclonal antibodies combined with adenovirus-vectored interferon significantly extend the treatment window in Ebola virus-infected guinea pigs.

Authors:  Xiangguo Qiu; Gary Wong; Lisa Fernando; Jane Ennis; Jeffrey D Turner; Judie B Alimonti; Xiaojian Yao; Gary P Kobinger
Journal:  J Virol       Date:  2013-04-24       Impact factor: 5.103

9.  Experimental inoculation of plants and animals with Ebola virus.

Authors:  R Swanepoel; P A Leman; F J Burt; N A Zachariades; L E Braack; T G Ksiazek; P E Rollin; S R Zaki; C J Peters
Journal:  Emerg Infect Dis       Date:  1996 Oct-Dec       Impact factor: 6.883

10.  Use of monoclonal antibodies against Hendra and Nipah viruses in an antigen capture ELISA.

Authors:  Cheng-Feng Chiang; Michael K Lo; Paul A Rota; Christina F Spiropoulou; Pierre E Rollin
Journal:  Virol J       Date:  2010-06-03       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.